On this page · 10 sections
Hereditary angioedema agents subcutaneous solution (10 mg/mL)

Ecallantide

Generic name: ecallantide

Brand names: Kalbitor

Last updated November 2, 2026 0 views
Share

What is ecallantide?

Ecallantide is used to treat attacks of hereditary angioedema (an immune system disorder). ecallantide is for use in adults and children who are at least 12 years old.

Ecallantide is not a cure for hereditary angioedema.

Ecallantide may also be used for reasons not mentioned in this medication guide.

This section was rewritten for readability and reviewed for meaning.

How is ecallantide given?

Ecallantide is given as an injection under the skin by a healthcare provider, typically in 3 separate injections.

You will be monitored closely to ensure you do not have an allergic reaction to the medication.

If you continue to have angioedema symptoms after 3 injections, more may be given within 24 hours.

This section was rewritten for readability and reviewed for meaning.

Warnings

Ecallantide can cause a serious allergic reaction within 1 hour after injection. Symptoms include wheezing, cough, trouble breathing or swallowing, itching, hives, dizziness, fainting, or swelling in your face or throat.

This section was rewritten for readability and reviewed for meaning.

Before taking this medicine

If you can, during an emergency, inform your caregivers about any allergies you have. Ensure that any doctor you see afterward knows you received ecallantide.

You should not receive ecallantide if you are allergic to it.

If you can, during an emergency, let your caregivers know if you are pregnant or breastfeeding.

This section was rewritten for readability and reviewed for meaning.

Ecallantide side effects

Ecallantide can cause a serious allergic reaction within 1 hour after injection. Tell your caregivers right away if you have:

  • chest pain or tightness, fast or weak heartbeat;
  • wheezing, cough, throat irritation, trouble breathing;
  • hoarse voice, tight feeling in your throat, trouble swallowing;
  • swelling of your lips, tongue, or throat;
  • swelling or redness in your face;
  • itching, rash, or hives;
  • flushing (warmth, redness, or tingly feeling);
  • sneezing, runny or stuffy nose; or
  • dizziness, feeling like you might pass out.

An allergic reaction may have the same symptoms as hereditary angioedema. Your caregivers will watch you closely and will quickly treat an allergic reaction.

Common side effects of ecallantide may include:

  • headache;
  • nausea, diarrhea;
  • fever;
  • stuffy nose, sore throat; or
  • skin reactions where the medicine was injected (redness, rash, itching, bruising, swelling).

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

This section was rewritten for readability and reviewed for meaning.

Ecallantide dosing information

Usual Adult Dose for Hereditary Angioedema:

30 mg subcutaneously in three 10 mg injections; may repeat an additional 30 mg within 24 hours if attack persists.

Usual Pediatric Dose for Hereditary Angioedema:

12 years and older: 30 mg subcutaneously in three 10 mg injections; may repeat an additional 30 mg within 24 hours if attack persists.

What happens if I miss a dose?

In a medical setting, it is unlikely that you will miss a dose.

This section was rewritten for readability and reviewed for meaning.

What happens if I overdose?

In a medical setting, an overdose would be treated quickly.

Follow your doctor's instructions about any limits on food, drinks, or activities.

This section was rewritten for readability and reviewed for meaning.

What other drugs will affect ecallantide?

Other drugs may affect ecallantide, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.

This section was rewritten for readability and reviewed for meaning.

Common questions about ecallantide

What type of drug is Takhzyro?
Takhzyro (lanadelumab-flyo) is a biologic medicine known as a monoclonal antibody and a plasma kallikrein inhibitor. It is used as a long‑term preventive treatment to help stop hereditary angioedema (HAE) attacks before they happen in people 2 years of age and older. Takhzyro is given as a self‑injection under the skin, usually every 2 or 4 weeks. It is not a rescue medicine for sudden HAE attacks. Continue reading

Related medicines

Before you take this medicine: the information on this page is general and may not cover your personal circumstances. Read the label supplied with your medicine and ask a pharmacist or doctor if you are unsure, especially if you are pregnant, breastfeeding, taking other medicines or managing a long-term condition.
General medicine information Consumer-friendly language

Content is provided for education and is not medical advice. See our medical disclaimer.